REQUEST A DEMO
Total
USD $0.00
Search more companies

Ascletis Pharma Inc. (歌礼制药有限公司) (Hong Kong SAR, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ascletis Pharma Inc. Profile Updated: April 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Ascletis Pharma Inc. (歌礼制药有限公司) is an enterprise located in Hong Kong SAR, China, with the main office in Hangzhou. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on April 20, 2026. Ascletis Pharma Inc. (歌礼制药有限公司) currently employs 202 (2025) people. In its most recent financial highlights, the company reported a net sales revenue increase of 57.47% in 2025. Its total assets decreased by 0.29% over the same period. The net profit margin of Ascletis Pharma Inc. (歌礼制药有限公司) increased by 5710.09% in 2025.

Headquarters
12/F, Building D, 198 Qidi Road Hipark, Xiaoshan District
Hangzhou; Zhejiang;

Contact Details: Purchase the Ascletis Pharma Inc. (歌礼制药有限公司) report to view the information.

Website: http://www.ascletis.com

Basic Information
Total Employees:
Purchase the Ascletis Pharma Inc. (歌礼制药有限公司) report to view the information.
Outstanding Shares:
Purchase the Ascletis Pharma Inc. (歌礼制药有限公司) report to view the information.
Registered Capital:
Purchase the Ascletis Pharma Inc. (歌礼制药有限公司) report to view the information.
Financial Auditors:
Purchase the Ascletis Pharma Inc. (歌礼制药有限公司) report to view the information.
Incorporation Date:
April 20, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
50.79%
Purchase this report to view the information.
8.18%
Purchase this report to view the information.
6.06%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Ap11 Limited (United Kingdom)
100%
Ascletis (Australia) Pty., Ltd (Australia)
100%
Powertree Investment (Bvi) Ltd. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Ascletis Pharma Inc. (歌礼制药有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
57.47%
Total Operating Revenue
N/A
Operating Profit
-10.48%
EBITDA
-8.8%
Net Profit/Loss for the Period
-19.14%
Total Assets
-0.29%
Total Equity
0.85%
Operating Profit Margin
9366.24%
Net Profit Margin
5710.09%
Return on Equity (ROE)
-3.3%
Debt / Equity
-0.12%
Quick Ratio
2.19%
Cash Ratio
5.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?